؉ channels (K ATP channels) of pancreatic ␤-cells play key roles in glucose-stimulated insulin secretion by linking metabolic signals to cell excitability. Membrane phosphoinositides, in particular phosphatidylinositol 4,5-bisphosphates (PIP 2 ), stimulate K ATP channels and decrease channel sensitivity to ATP inhibition; as such, they have been postulated as critical regulators of K ATP channels and hence of insulin secretion in ␤-cells. Here, we tested this hypothesis by manipulating the interactions between K ATP channels and membrane phospholipids in a ␤-cell line, INS-1, and assessing how the manipulations affect membrane excitability and insulin secretion. We demonstrate that disruption of channel interactions with PIP 2 by overexpressing PIP 2 -insensitive channel subunits leads to membrane depolarization and elevated basal level insulin secretion at low glucose concentrations. By contrast, facilitation of channel interactions with PIP 2 by upregulating PIP 2 levels via overexpression of a lipid kinase, phosphatidylinositol 4-phosphate 5 kinase, decreases the ATP sensitivity of endogenous K ATP channels by ϳ26-fold and renders INS-1 cells hyperpolarized, unable to secrete insulin properly in the face of high glucose. Our results establish an important role of the interaction between membrane phosphoinositides and K ATP channels in regulating insulin secretion. Diabetes 54:2852-2858, 2005 P ancreatic ␤-cells secrete insulin in response to glucose stimulus. The ATP-sensitive K ϩ (K ATP ) channel, a complex of four inwardly rectifying K ϩ channel Kir6.2 subunits and four sulfonylurea receptor 1 (SUR1) subunits, is a key component in this stimulus-secretion coupling process (1-3). The hallmark features of K ATP channels are their sensitivities to intracellular nucleotides ATP and ADP, the derivatives of glucose metabolism (1,2). ATP inhibits channel activity, whereas ADP, in complex with Mg 2ϩ , stimulates channel activity. It is now generally accepted that the physiological activity of K ATP channels is regulated primarily by the relative concentrations of ATP and ADP (1,4,5). As plasma glucose increases, ATP concentration increases and ADP concentration decreases, resulting in K ATP channel closure, membrane depolarization, Ca 2ϩ influx, and insulin release. Conversely, when glucose decreases, the concentration ratio of ATP to ADP decreases, leading to K ATP channel opening, membrane hyperpolarization, and termination of insulin secretion. The importance of ATP and ADP in regulating K ATP channels in vivo has been confirmed by the finding that mutations that reduce channel sensitivity to ATP or MgADP are causative in permanent neonatal diabetes or congenital hyperinsulinism, respectively (5-9).
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؉ channels (K ATP channels) of pancreatic ␤-cells play key roles in glucose-stimulated insulin secretion by linking metabolic signals to cell excitability. Membrane phosphoinositides, in particular phosphatidylinositol 4,5-bisphosphates (PIP 2 ), stimulate K ATP channels and decrease channel sensitivity to ATP inhibition; as such, they have been postulated as critical regulators of K ATP channels and hence of insulin secretion in ␤-cells. Here, we tested this hypothesis by manipulating the interactions between K ATP channels and membrane phospholipids in a ␤-cell line, INS-1, and assessing how the manipulations affect membrane excitability and insulin secretion. We demonstrate that disruption of channel interactions with PIP 2 by overexpressing PIP 2 -insensitive channel subunits leads to membrane depolarization and elevated basal level insulin secretion at low glucose concentrations. By contrast, facilitation of channel interactions with PIP 2 by upregulating PIP 2 levels via overexpression of a lipid kinase, phosphatidylinositol 4-phosphate 5 kinase, decreases the ATP sensitivity of endogenous K ATP channels by ϳ26-fold and renders INS-1 cells hyperpolarized, unable to secrete insulin properly in the face of high glucose. Our results establish an important role of the interaction between membrane phosphoinositides and K ATP channels in regulating insulin secretion. Diabetes 54:2852-2858, 2005 P ancreatic ␤-cells secrete insulin in response to glucose stimulus. The ATP-sensitive K ϩ (K ATP ) channel, a complex of four inwardly rectifying K ϩ channel Kir6.2 subunits and four sulfonylurea receptor 1 (SUR1) subunits, is a key component in this stimulus-secretion coupling process (1) (2) (3) . The hallmark features of K ATP channels are their sensitivities to intracellular nucleotides ATP and ADP, the derivatives of glucose metabolism (1, 2) . ATP inhibits channel activity, whereas ADP, in complex with Mg 2ϩ , stimulates channel activity. It is now generally accepted that the physiological activity of K ATP channels is regulated primarily by the relative concentrations of ATP and ADP (1, 4, 5) . As plasma glucose increases, ATP concentration increases and ADP concentration decreases, resulting in K ATP channel closure, membrane depolarization, Ca 2ϩ influx, and insulin release. Conversely, when glucose decreases, the concentration ratio of ATP to ADP decreases, leading to K ATP channel opening, membrane hyperpolarization, and termination of insulin secretion. The importance of ATP and ADP in regulating K ATP channels in vivo has been confirmed by the finding that mutations that reduce channel sensitivity to ATP or MgADP are causative in permanent neonatal diabetes or congenital hyperinsulinism, respectively (5) (6) (7) (8) (9) .
The discovery that membrane phosphoinositides, in particular the most abundant phosphoinositide phosphatidylinositol 4,5-bisphosphate (PIP 2 ) (10), stimulate K ATP channel activity and antagonize the inhibitory effect of ATP in isolated membrane patches (11, 12) has led to the proposal that in addition to ATP and ADP, PIP 2 may also be important in controlling the physiological activity of K ATP channels in ␤-cells (11) (12) (13) (14) . However, to date, direct evidence for a role of membrane phosphoinositides in regulating K ATP channel activity, hence regulation of insulin secretion, in ␤-cells is still lacking (15) .
In addition to modulating the activity of transporters and ion channels, phosphoinositides play significant roles in membrane trafficking and cytoskeleton organization (16, 17) . Recent studies show that adequate PIP 2 levels are necessary for cytoskeleton rearrangement and priming of insulin secretory granules (18, 19) . These studies highlight the complex role of phosphoinositides in insulin secretion and the need to elucidate the physiological relevance of K ATP channel gating by PIP 2 in the context of ␤-cell function and insulin secretion. In this study, we manipulated the interactions between K ATP channels and membrane PIP 2 in insulin-secreting cells and examined the effects of such manipulations on K ATP channel activity and insulin secretion. We show that disrupting the interaction between K ATP channels and PIP 2 by overexpressing Kir6.2 mutants with decreased sensitivity to PIP 2 causes persistent membrane depolarization and elevated basal level insulin secretion. On the other hand, promoting channel-PIP 2 interactions by expressing a murine type I␤ phosphatidylinositol 4-phosphate 5 kinase (PIP5K) (20, 21) , which increases PIP 2 levels and thereby K ATP channel activity, renders INS-1 cells less able to couple glucose stimulation to insulin secretion. The results provide direct evidence that regulation of K ATP channel activity by phosphoinositides plays an integral role in insulin secretion.
RESEARCH DESIGN AND METHODS
Molecular biology. Kir6.2 containing point mutations or the influenza A virus hemagglutinin (HA)-epitope tag (YPYDVPDYA inserted between amino acid 100 and 101 of Kir6.2; an extra nine amino acids, DLYAYMEKG, inserted between amino acid 98 and 99 to aid accessibility of the epitope) were prepared using the QuickChange site-directed mutagenesis kit (Stratagene) and subcloned into the pCMV6b vector. Recombinant adenoviruses were constructed using the AdEasy system (Stratagene). The cDNAs encoding wild-type PIP5K I␤ (PIP5K:WT) or a deletion mutant lacking the NH 2 -terminal 238 amino acids (PIP5K:⌬1--238) (20) or the various rat Kir6.2 wild type and mutants were subcloned into the pCMV shuttle vector (pShuttle). They were then recombined with the pAdEasy vector in the BJ5183 strain of Escherichia Coli. Positive recombinants were selected, and pAdEasy plasmids containing the correct insert were used to transfect HEK293 cells for virus production. Single plaques were isolated for further amplification in HEK293 cells. Recombinant viruses were purified on a CsCl gradient and titers determined by spectrometry. All constructs were sequenced to verify the correct mutations. Ci 32 P for 4 h. Cells were then washed twice with phosphate-free medium and scraped into 1 ml MeOH:HCl (10:1). After scraping, the dish was washed again with 1 ml of 2-mmol/l AlCl 3 in H 2 O, and the wash was combined with the cell lysate. The lipids were extracted by 2 ml CHCl 3 . The aqueous phase was transferred to a new tube and extraction repeated twice. The CHCl 3 phase from the three extractions was combined and extracted with 2 ml MeOH:HCl (1: and 5 ATP. The pH of all solutions was adjusted to ϳ7.2. To measure RMP without dialyzing internal cellular contents, the perforated patch was adopted. The pipette resistance ranged between 3 and 5 M⍀. The tip solution was first filled up to ϳ0.5 mm with the clean pipette solution containing (in mmol/l) 76 K 2 SO 4 , 10 NaCl, 10 KCl, 1 MgCl 2 , and 5 HEPES, pHϳ7.2; the pipette was then backfilled with the pipette solution containing ϳ160 -250 g/ml amphotericin B (Sigma). The stable perforated patch usually followed after 6 -10 min of initial Giga seal. For ATP sensitivity measurement, inside-out patch-clamp recording was used as described previously (21) . K-INT was used in both the bath and pipette solution. All currents were measured at a membrane potential of Ϫ50 mV (pipette voltage ϭ ϩ50 mV). ATP dose-response curves were fitted by the Hill equation:
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H }, where I rel ϭ current in [ATP]/current in 0 ATP, H ϭ Hill coefficient, and K 1/2 ϭ [ATP] causing half-maximal inhibition. All data are presented as means Ϯ SE.
Membrane capacitance measurements were carried out in the standard whole-cell configuration using an EPC-9 amplifier and Pulse software (version 8.4; Heka Elektronik, Lambrecht, Germany). Patch electrodes were made from borosilicate glass capillaries, coated with dental wax (Kerr, Romulus, MI) at the tips, and fire polished. The cells were constantly perfused with prewarmed extracellular solution consisting of (in mmol/l) 138 NaCl, 5.6 KCl, 1.2 MgCl 2 , 2.6 CaCl 2 , and 5 HEPES (pH 7.4 with NaOH). The pipette solution contained (in mmol/l) 125 CsMeSO, 25 CsCl, 10 NaCl, 1 MgCl 2 , 10 HEPES, 0.05 EGTA, 3 Mg ATP, and 0.01 GTP, pH 7.2. The temperature close to the cell was 32-34°C. Exocytosis was elicited by a train of six (at 1 Hz) 300-ms voltageclamp depolarization from Ϫ70 mV to 0 and detected as changes in cell capacitance estimated by the Lindau-Neher technique ("Sine ϩ DC" feature of the lock-in software module). The amplitude of the sine wave was 20 mV, and the frequency set as 500 Hz. Insulin secretion assay. INS-1 cells were seeded in 24-well tissue culture plates at ϳ5 ϫ 10 5 /well, cultured for ϳ24 h, and infected with viruses as described above. Twenty-four hours postinfection, the culture medium was replaced by RPMI-1640 with 5 mmol/l glucose and cells incubated for at least 18 h. Insulin secretion was assayed in HEPES balanced salt solution (HBSS) consisting of (in mmol/l) 114 NaCl, 4. (22) . Cells were washed twice with prewarmed (37°C) HBSS buffer with 3 mmol/l glucose followed by 2-h incubation in the same buffer before stimulation with 0.8 ml/well prewarmed HBSS buffer containing 3 or 12 mmol/l glucose for 2 h. The medium was harvested and insulin content determined using Immunochem coated-tube insulin radioimmunoassay from ICN Pharmaceuticals (Costa Mesa, CA). Insulin release in different concentrations of glucose was normalized to that observed at 3 mmol/l glucose and expressed as fold increase.
RESULTS
Disruption of K ATP channel-PIP 2 interactions in INS-1 cells results in depolarized membrane potential and increased basal level insulin secretion. PIP 2 exerts its effect on K ATP channel gating largely via the Kir6.2 subunit (11, 12) . There is evidence that binding of the negatively charged phosphate groups of membrane PIP 2 to the cytoplasmic domain of Kir6.2 leads to channel opening (11,12,24 -27) . Several positively charged Kir6.2 residues critical for channel gating by PIP 2 have been identified, including R176, R177, and R206 (27, 11) . Mutation of these residues to the neutral amino acid alanine either reduces or abolishes channel activity in inside-out membrane patches in the absence of inhibitory ATP (these mutants are referred to as PIP 2 -insensitive mutants hereinafter). To elucidate the role of K ATP channel-PIP 2 interactions in ␤-cell excitability and insulin secretion, we sought to disrupt channel-PIP 2 interactions by overexpressing PIP 2 -insensitive Kir6.2 mutants in the rat ␤-cell line INS-1 clone 832/13, which exhibits robust insulin response to glucose stimulation (22) . In COS cells, coexpression of the PIP 2 -insensitive Kir6.2 mutant with wildtype Kir6.2 (WT Kir6.2) at 1:1 molar ratio in the presence of SUR1 led to a Ͼ50% reduction in total K ATP currents (data not shown). Mutant Kir6.2 expressed in INS-1 cells is therefore expected to compete with endogenous WT Kir6.2 for incorporation into the channel complex and reduces overall channel sensitivity to PIP 2 . Reduced K ATP channel activity is in turn expected to cause membrane depolarization even in the absence of glucose stimulation (28) . We have chosen the recombinant adenovirus approach for expressing mutant Kir6.2 in INS-1 cells because it is much more efficient than conventional transfection methods (29) ; infection with adenoviruses carrying the green fluorescence protein (GFP) gene yielded Ͼ95% GFP-positive cells 12 h after infection.
As shown in Fig. 1 , in cells expressing the R176A, R177A, or the R206A Kir6.2 mutant, the RMP (as assessed by whole-cell patch-clamp recording with pipette solution containing 1 mmol/l ATP and 1 mmol/l MgCl 2 ) in low (3 mmol/l) glucose was indeed significantly more depolarized (approximately Ϫ35 to 40 mV) than that observed in uninfected control cells (approximately Ϫ72 mV) or cells expressing either GFP (approximately Ϫ74 mV) or WT Kir6.2 (approximately Ϫ69 mV). To further validate the membrane potential obtained using whole-cell patchclamp recording, we also measured membrane potential using perforated patch-clamp recording, a procedure that better preserves the intracellular milieu. A substantially more depolarized membrane potential was again observed in cells infected with the PIP 2 -insenstive R177A Kir6.2 mutant compared with uninfected cells or cells infected with WT Kir6.2 at low (3 mmol/l) glucose (Fig. 1C) but not at high (12 mmol/l) glucose (not shown). Note that the membrane potential obtained using the perforated patchclamp technique was ϳ20 mV more depolarized than that obtained by whole-cell recording after dialysis with 1 mmol/l MgATP. The difference likely reflects the higher intracellular MgATP concentration in intact INS-1 cells. The above results are consistent with the notion that K ATP channel-membrane PIP 2 interactions are necessary to sustain K ATP channel activity and maintain the membrane potential at the resting hyperpolarized state in the absence of glucose stimulation. The depolarized membrane potential in cells expressing mutant Kir6.2 could largely be hyperpolarized to the level seen in uninfected cells (R206A, for example) by adding the K ATP channel opener diazoxide in the bath solution, demonstrating that the depolarized membrane potential is not due to adverse effects of virus infection or mutant Kir6.2 expression on the health of the cell. Although PIP 2 -insenstive Kir6.2 mutants have been reported to render the channel less responsive to diazoxide (30, 31) , residual sensitivity of mutant channels to the channel opener as well as endogenous WT Kir6.2 subunits present in some channels may be sufficient to confer the diazoxide sensitivity we observed.
To ensure that the titer of each recombinant Kir6.2 adenovirus used for infection gives rise to similar protein expression level, we analyzed Kir6.2 protein level by immunoblotting. Furthermore, to confirm that the mutant Kir6.2 subunit is incorporated into the channel complex and expressed on the surface of INS-1 cells, we tagged one of the mutant R206A with a HA-epitope tag in the extracellular domain between amino acids 100 and 101 (HA-R206A-Kir6.2). This extracellular epitope tag allows for evaluation of surface expression of the mutant without permeabilizing the cell; the HA-tag does not interfere with the function of the channel (data not shown). As Fig. 2A illustrates, the titer of each of the WT-, R176A-, R177A-, or HA-R206A-Kir6.2 viruses could be adjusted to obtain similar protein expression levels (approximately fivefold of endogenous Kir6.2). Immunofluorescent staining of HA-R206A-Kir6.2 also confirmed that the mutant protein is indeed incorporated into the channel complex and expressed at the cell surface (Fig. 2B) .
Next, we evaluated insulin secretion response in cells expressing the various PIP 2 -insensitive Kir6.2 mutants at both low (3 mmol/l) and high (12 mmol/l) glucose concentrations. These glucose concentrations represent basal and maximal insulin response to glucose stimulation, respectively, based on a glucose dose-response curve (0 -20 mmol/l glucose) established in INS-1 cells (not shown) (22) . To exclude a direct effect of the Kir6.2 mutant on the insulin secretory machinery, we first measured membrane capacitance changes in response to 500 ms voltage-clamp depolarization. In these experiments, effects of channel-PIP 2 interactions on the membrane potential are excluded and the capacitance change represents fusion of insulin granules that are available for immediate release upon the evoked membrane depolarization. Figure 2C shows that no significant difference in capacitance increase is detected between GFP virusinfected control cells and cells expressing HA-R206A-Kir6.2. Insulin secretion assays demonstrated that at 3 mmol/l glucose, while cells infected with WT-Kir6.2 virus had insulin secretion response indistinguishable from that observed in uninfected control cells (1.1-fold), cells infected with each of the three PIP 2 -insensitive Kir6.2 mutants all exhibited significantly elevated insulin secretion (1.9-, 2.4-, and 3.6-fold that of uninfected cells for R176A, R177A, and HA-R206A, respectively; Fig. 2D ). These results are consistent with the electrophysiological data ( Fig. 1) showing depolarized membrane potential in cells expressing the PIP 2 -insensitive mutants. As expected, at a high glucose concentration (12 mmol/l) no significant difference in insulin secretion response could be discerned between cells expressing the various Kir6.2 or uninfected cells because the membrane depolarizing effect caused by the mutant Kir6.2 is now masked by the depolarizing effect caused by high glucose stimulation. Also consistent with the electrophysiological data, treatment of cells with diazoxide reversed the elevated basal level insulin secretion in cells expressing the PIP 2 -insensitive Kir6.2 mutants to various extents (Fig. 2E) . The results described above provide strong evidence that K ATP channel-PIP 2 interactions are necessary to allow channel opening and to prevent insulin secretion when glucose concentrations are low. Enhancing K ATP channel-PIP 2 interactions reduces channel sensitivity to ATP inhibition and attenuates membrane depolarization and insulin secretion upon glucose stimulation. To assess how increased interactions between K ATP channels and PIP 2 affect ␤-cell excitability and insulin secretion, we sought to upregulate PIP 2 levels by overexpressing lipid kinase PIP5K:WT (murine type I isoform ␤), which is involved in the synthesis of phosphatidylinositol 4,5-P 2 (10, 20, 21) . Overexpression of PIP5K:WT in COSm6 cells has previously been shown to decrease the ATP sensitivity of K ATP channels exogenously expressed in those cells (21) . As a negative control, we infected cells with viruses carrying a mutant kinase whose NH 2 -terminal 238 amino acids have been deleted to remove its enzymatic activity (referred to as PIP5K:⌬1-238) (20, 21) . Figure 3A (Fig. 3B) . The amount of PIP 2 in cells expressing PIP5K:WT was dramatically increased (ϳ30-fold) compared with uninfected cells or cells expressing PIP5K:⌬1-238.
We next examined how the increased PIP 2 affects K ATP channel activity by inside-out patch-clamp recording. In these experiments, patches were excised into K-INT solution with no ATP and then exposed quickly to K-INT containing various concentrations of ATP (all in the ab- sence of Mg 2ϩ ) before any significant current rundown occurred to ensure accurate measurement of ATP dose response ( Fig. 4A) (21) . As shown in Fig. 4B , K ATP channels in cells infected with the PIP5K:WT virus exhibited a ϳ26-fold decrease in ATP sensitivity compared with channels in uninfected cells or cells infected with the PIP5K:⌬1-238 virus. The large rightward shift in ATP dose response is predicted to cause K ATP channels to remain active even when the glucose level rises, resulting in hyperpolarized membrane potential and reduced insulin response. To test these, we examined the membrane potential at high glucose using a perforated patch-clamp technique. As mentioned above, the perforated-patch recording permits measurement of membrane potential without disturbing intracellular factors that are involved in regulating K ATP channel activity. Indeed, we found that at 12 mmol/l glucose, the averaged membrane potential is significantly more hyperpolarized in cells infected with the PIP5K:WT virus than in uninfected cells or cells infected with the PIP5K:⌬1-238 virus (Fig. 4C) . Similar results were obtained using whole-cell recordings with 12 mmol/l glucose in the bath solution and 5 mmol/l ATP plus 3 mmol/l Mg 2ϩ in the pipette solution (not shown). Accordingly, while in uninfected cells or cells infected with the PIP5K:⌬1-238 virus increasing the glucose concentration from 3 to 12 mmol/l led to a 9.5-and 8.4-fold increase in insulin release, respectively, in cells infected with the PIP5K:WT virus the same glucose concentration change only caused a 3.5-fold increase in insulin release (Fig. 5A ). This reduced secretion is not due to an inability of insulin granules to fuse with the membrane because no difference in membrane capacitance increase was found between cells infected with the PIP5K:WT virus and uninfected cells either during the first depolarization or during an entire train of step voltage-clamp depolarizations (Fig. 5C ). In addition, overexpression of PIP5K did not alter voltage-gated Ca 2ϩ currents during these experiments (shown as the charge influx in Fig. 5D ) (32) . These results lead us to conclude that overexpression of PIP 2 reduces insulin secretion at high glucose by rendering K ATP channels insensitive to ATP.
DISCUSSION
Despite the effects of membrane phosphoinositides, especially PIP 2 , on K ATP channel activity having been well documented in vitro studies for some time (11, 12, 33, 34) , the relevance of channel regulation by PIP 2 to insulin secretion remains controversial (15, 35) . To address this issue, it is necessary to directly correlate the interactions between K ATP channels and PIP 2 in ␤-cells to insulin secretion. INS-1 clone 832/13 is a rat insulinoma cell line widely used to study ␤-cell function; it exhibits robust glucose-stimulated insulin secretion, mediated by both K ATP -dependent and independent pathways (22) . Our studies demonstrate that alterations in K ATP channel-PIP 2 interactions have profound effects on insulin secretion, establishing a physiological role of PIP 2 in controlling insulin secretion through K ATP channel regulation.
In altering channel-PIP 2 interactions, we took two approaches: one by manipulating the channel subunit Kir6.2, the other by manipulating cellular PIP 2 levels. While interpretation of experiments in which Kir6.2 subunit is the subject of manipulation is straightforward, interpretation of experiments involving the manipulation of PIP 2 concentrations is more complicated due to its role in diverse cellular processes. For example, recent studies indicate that PIP 2 is required for recruitment of insulin granules to the release sites during the secondary phase of insulin secretion: a decrease in PIP 2 levels reduces, whereas an increase in PIP 2 levels enhances insulin secretion (18, 19) . In addition, PIP 2 has been shown to control the rate of endocytosis (36 -38) . Curiously, unlike that reported in primary ␤-cells and chromaffin cells (18,39) , we did not detect a significantly larger increase in membrane capacitance change upon direct voltage-clamp membrane depolarization in INS-1 cells with elevated PIP 2 ( Fig.  5B and C) . The discrepancy might be due to differences in the level of PIP 2 overexpression; the prolonged high level of PIP 2 seen in PIP5K:WT virus-infected INS-1 cells might lead to increased membrane endocytosis, masking the capacitance increase expected from enhanced exocytosis. Regardless, even if there is an effect of PIP 2 that acts directly on the exocytotic machinery, this effect is likely to be small compared with the effect of PIP 2 via K ATP channels, as the net result of PIP 2 overexpression in our experiments is a decrease in glucose-induced insulin secretion (Fig. 5A ). Increased endocytosis due to elevated PIP 2 might also affect the level of membrane proteins involved in stimulation-secretion coupling, such as K ATP channels. If true, this would lead to fewer K ATP channels at the cell surface and increased insulin secretion, making our observed impact of enhanced channel-PIP 2 interaction on insulin secretion an underestimate. Taken together, despite the multiple mechanisms by which PIP 2 may affect insulin secretion, our observation that elevated PIP 2 dramatically reduces the ATP sensitivity of endogenous K ATP channels (Fig. 4) provides strong consistency with a critical role of membrane PIP 2 in controlling ␤-cell K ATP channel activity and hence ␤-cell excitability and insulin secretion.
In conclusion, our study demonstrates that membrane phosphoinositides play an integral role in determining the activity of K ATP channels in ␤-cells. Many hormones, neurotransmitters, and nutrients affect the metabolism of phosphoinositides in ␤-cells (40 -44) . Our finding raises the possibility that variation in membrane phosphoinositides under normal and pathological conditions may affect insulin secretion by altering K ATP channel activity. Mutations in other Kir channels such as Kir2.1 that impair channel sensitivity to PIP 2 have been shown to underlie Anderson syndromes (45) . Our study also raises the possibility that naturally occurring mutations in Kir6.2 that alter channel-PIP 2 interactions may cause insulin secretion diseases.
